Medical Advancement Highlights

The advancements in medicine are both miraculous and plentiful. Of late there have been quite a few significant breakthroughs and innovative studies, the following of which were announced by the American Heart Association in 2020 alone…

There is now a new, minimally invasive surgery to prevent stroke in those suffering from atrial fibrillation (AFib). Additionally, even though high blood pressure is one of the most treatable risk factors for heart disease and stroke, the United States has recently lost ground in this arena, prompting certain studies. One of which reported that those with health insurance were 43 to 54 percent more likely to adequately control their blood pressure, while only 24 percent of those without health insurance were able to properly control their high blood pressure. The American Heart Association has also conducted studies to improve hypertrophic cardiomyopathy, which is the thickening and stiffening of the heart.

Recently, through much research and many clinical trials, medical professionals have also gained greater insight and understanding of infectious diseases, such as COVID-19 and influenza and the potential risk they create for heart disease and stroke.

However, recent medical advancements and innovations have extended far further than matters of the heart. This past year, we have learned that certain diabetes medications, such as sodium glucose transporter 2 inhibitors, can help heart failure patients, regardless of whether or not they have been diagnosed with diabetes. Medical researchers are also currently developing technologies for early cancer detection and diagnosis of a progressive form of dementia through blood tests. In addition, scientific researchers are looking into DNA sequence patterns to better determine when certain cancers may begin to develop.  There is also research being conducted to develop a compound which minimizes prostate cancer cell growth, as well as ways to control genetic mutations.

There are new medications for cystic fibrosis which provide relief to approximately 90 percent of those diagnosed with the most common cystic fibrosis gene mutation. There have been vast improvements in the area of hepatitis C medication, helping an even larger scope of these patients; and a new drug has been developed that can treat 15 percent more people diagnosed with multiple sclerosis. There is also now gene therapy for blood disorders – one reducing the amount of ineffective red blood cells in those with sickle cell anemia. Plus, unlike mechanical ventilation, a “bubble CPAP” has been developed that non-invasively increases lung function in premature babies. 

And maybe not so recently, but just as earth-shattering, medical advancements have included success with block proteins that can delay the progression in certain prostate cancers. A low-technology, postpartum hemorrhage solution, which is particularly helpful in developing countries with limited medical resources, has been developed. There is also a new class of migraine prevention medication and a combination drug therapy approach for patients suffering from HIV.

 

The medical community has also made advancements in producing, storing and sharing information. We now have imaging software that allows doctors to digitally access patient test results, X-rays and MRIs. There is even scanning software available which scans patient files into a central database and allows medical professionals to quickly access every patient’s information in order to provide more informed and immediate diagnosis and treatment. This seamless exchange of medical information can be provided over a wide spectrum of disciplines, doctors’ offices and even countries, improving cost-effectiveness as well as efficiency of service.

Plus, amazing technological advancements in medicine have increased access to telemedicine, have connected smartphones to implanted pacemakers and defibrillators to enhance physician monitoring and help prevent and correct heartbeat irregularities; provided surgeons with real-time helpful information in their line of sight during surgeries; and have made minimally invasive robotic surgery – which minimizes incision size and recovery size – possible…and this all just scratches the surface of the innovations – recent and not so recent – that vastly improve our daily lives.

Velocity Clinical Research, formerly Riverside Clinical Research, plays an integral role in the advancement of medicine. As part of a celebrated clinical research team with centuries of proven experience, our Velocity Clinical Research facility provides compassionate patient care; trusted clinical expertise, state-of-the-art technology and knowledgeable medical research veterans to expedite the highest quality clinical data; as well as exceptional advantages and benefits for our clinical trial volunteers.

The medical professionals at Velocity Clinical Research in Edgewater are dedicated to the tireless pursuit of extraordinary advancements in medicine and treatments; and having become a part of the Velocity Clinical Research organization also enables us to expand our efficacy and services so that we are able to conduct an even broader range of clinical trials in the hopes of discovering an even wider array of remarkable treatments. 

Velocity Clinical Research will also continue to provide rapid responsiveness in all areas, from initial feasibility studies, to patient enrollment, through to successful clinical study completion; a comfortable environment for clinical volunteers; all of which result in our maintenance of unprecedented levels of patient retention and the consistency of quality referrals.

If you would like to learn more about Velocity Clinical Research and the clinical trial studies we are currently scheduling and conducting, please feel free to call 386-428-7730 Monday through Thursday from 7 a.m. to 5 p.m. or Friday from 7 a.m. to 12 p.m.

You are also welcome to access the patient portal on our website and enroll with Velocity Clinical Research so that you may be contacted about studies conducted in your area. Velocity Clinical Research can also be reached by email at info@velocityclinicalresearch.com